AstraZeneca Plc (NASDAQ:AZN) reported initial data from the TROPION-PanTumor01 Phase 1 trial of datopotamab deruxtecan (Dato-DXd). The data showed encouraging and…
NVIDIA's (NASDAQ:NVDA) short percent of float has risen 3.7% since its last report. The company recently reported that it has 39.68 million shares sold short, which is 1.68% of all regular shares that are available for trading.